当前位置：
X-MOL 学术
›
Dermatol. Ther.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Effectiveness and safety of switching from originator to biosimilar adalimumab in patients with psoriasis.
Dermatologic Therapy ( IF 3.7 ) Pub Date : 2020-08-31 , DOI: 10.1111/dth.14258 Valdemar Wendelboe Nielsen 1 , Tamara Theresia Lund 1 , Robert Gniadecki 2 , Rasmus Huan Olsen 1, 3 , Christoffer Valdemar Nissen 1 , Jakob Ferløv Baselius Schwensen 1 , Simon Francis Thomsen 1, 4
中文翻译：
银屑病患者从原始药物转为仿生阿达木单抗的有效性和安全性。
更新日期：2020-08-31
Dermatologic Therapy ( IF 3.7 ) Pub Date : 2020-08-31 , DOI: 10.1111/dth.14258 Valdemar Wendelboe Nielsen 1 , Tamara Theresia Lund 1 , Robert Gniadecki 2 , Rasmus Huan Olsen 1, 3 , Christoffer Valdemar Nissen 1 , Jakob Ferløv Baselius Schwensen 1 , Simon Francis Thomsen 1, 4
Affiliation
中文翻译：
银屑病患者从原始药物转为仿生阿达木单抗的有效性和安全性。
京公网安备 11010802027423号